Molecular, Pathologic Intra Tumoral Heterogeneity in Malignant Pleural Mesothelioma
- Conditions
- Gene AbnormalityMesothelioma, MalignantPleural Mesothelioma
- Registration Number
- NCT04823741
- Lead Sponsor
- Hospices Civils de Lyon
- Brief Summary
Malignant pleural mesothelioma (MPM) is a rare pleural cancer, which could be primary or secondary to an asbestos exposure. To enhance our knowledge of this rare disease, an exploration of genetic and tumor mechanism is mandatory. One of the principal difficulty is to harvest sufficient tumour pieces to perform multi-omics analysis. The goal of the SCITH-MESO study is to harvest larges pieces of tumour during a routine surgical procedure of MPM diagnosis by mean of pleural biopsies during VATS surgery. Operating samples will increase a tissue bank collection (CRB).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 30
- age >18
- suspected MPM requiring VATS biopsy after multidisciplinary oncologic board validation
- patient able to understand study objectives and able to give an informed consent
- patient affiliated to an healthcare society.
- pregnancy
- mental disease, psychiatric disorder
- patient under protection regimen
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method For patients with MPM, blood samples are collected and a piece of biopsy will be used for the constitution of a specific bio collection in the CRB (centre de ressources biologiques). day 1 (day of chirurgie) For patients with MPM, blood samples are collected and a piece of biopsy will be used for the constitution of a specific bio collection in the CRB (centre de ressources biologiques).
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Département de chirurgie thoracique
🇫🇷Bron, France
Département de chirurgie thoracique🇫🇷Bron, FranceJean Michel MAURYContact04.72.35.75.90jean-michel.maury@chu-lyon.fr
